Back to Search
Start Over
The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
- Source :
-
Pathology, research and practice [Pathol Res Pract] 2009; Vol. 205 (1), pp. 35-41. Date of Electronic Publication: 2008 Oct 31. - Publication Year :
- 2009
-
Abstract
- The aim of this study was to investigate the effects of antenatal steroid treatment and/or postnatal surfactant replacement therapy on the incidence and extent of selected histopathological findings. Seventy complete autopsies were reviewed, and only lung tissues were examined and graded. Infants were divided into treatment and control groups as follows: group 1: surfactant-treated infants (n=15); group 2: infants whose mothers were given steroid treatment (n=16); group 3: surfactant-treated infants whose mothers were given steroid treatment (n=10). The control group included 29 patients not treated with surfactant and steroid. The overall incidence and severity of hyaline membrane and pulmonary hemorrhage were similar in each treatment group when compared to the control group. However, when the treatment groups were compared with each other, the incidence of severe hyaline membrane was more common in group 1 than in group 3. A significant reduction in severe hyaline membrane was associated with combined surfactant and antenatal steroid therapy. However, the cause for the similar incidence of selected histopathological findings in the treatment groups and the control group may be linked to oxygen toxicity due to insufficient antioxidant capacity in premature infants and barotrauma from mechanical ventilation.
- Subjects :
- Autopsy
Drug Therapy, Combination
Female
Gestational Age
Hemorrhage drug therapy
Hemorrhage pathology
Humans
Hyaline Membrane Disease drug therapy
Hyaline Membrane Disease pathology
Infant, Newborn
Lung pathology
Male
Pneumonia drug therapy
Pneumonia pathology
Pulmonary Atelectasis drug therapy
Pulmonary Atelectasis pathology
Pulmonary Emphysema drug therapy
Pulmonary Emphysema pathology
Respiratory Distress Syndrome, Newborn pathology
Severity of Illness Index
Treatment Outcome
Adrenal Cortex Hormones therapeutic use
Infant, Premature
Lung drug effects
Pulmonary Surfactants therapeutic use
Respiratory Distress Syndrome, Newborn drug therapy
Respiratory System Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 0344-0338
- Volume :
- 205
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Pathology, research and practice
- Publication Type :
- Academic Journal
- Accession number :
- 18951732
- Full Text :
- https://doi.org/10.1016/j.prp.2008.08.004